Harms of prostate cancer screening exceed benefits, study says

10/1/2013 | Medscape (free registration)

The overall harms of prostate cancer screening through prostate-specific antigen tests outweigh the benefits, according to a study presented at the European Cancer Conference. PSA testing can lead to impaired quality of life, and some statistics indicate it has not reduced mortality, lead author Dr. Mathieu Boniol said.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA